D. Heg

Discipline

Economies et finances (2) Psychologie (1)

Type de document

Articles (10)

Co-auteur

Date

Source

Mot-clé

Patients (10) Patients (10) Treatment (9) Human beings (8) Death (6) Myocardial infarction (6) Death (6) mort (6) risque (5) procès (5) Ci (Chinese poetry) (5) Risk (5) Older people (5) polymère (4) analyse (4) danger (4) Rates (4) Prosthesis (4) Design (4) Cerebrovascular disease (4) Drug-eluting stents (4) Design (4) Analysis (4) Rates (4) cohorte (4) temps (durée) (3) thérapie (3) sécurité (3) effet (3) âge (3)

Documents écrit par D. Heg (10) | parle de D. Heg (0)

Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions: A lesion-level subgroup analysis of 2 randomized trials.
J.D. Häner et al.
Effect of phosphodiesterase-5 inhibition on SystEmic Right VEntricular size and function. A multicentre, double-blind, randomized, placebo-controlled trial: SERVE.
M. Greutmann et al.
Five-Year Outcomes With Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute Coronary Syndrome: A Subgroup Analysis of the BIOSCIENCE Trial.
J.F. Iglesias et al.
Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI: Final 2-Year Outcomes of the BIOSTEMI Trial.
T. Pilgrim et al. (22 mars 2021)
Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention.
D. Carballo et al. (2019)
Incidence, Predictors, and Clinical Impact of Early Prasugrel Cessation in Patients With ST-Elevation Myocardial Infarction.
K.C. Koskinas et al. (13 avr. 2018)
Prognosis of cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome.
S. Canivell et al. (2018)
Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes.
B. Gencer et al. (9 nov. 2017)
Repositionable Versus Balloon-Expandable Devices for Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis.
T. Pilgrim et al. (17 nov. 2016)
Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE Trial.
R. Zbinden et al. (2016)